We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Machine Learning Analyzes MRI Data to Predict Brain Tumor Progression

By MedImaging International staff writers
Posted on 17 Jan 2023
Researchers have used MRI data to further personalize cancer medicine (Photo courtesy of Pexels)
Researchers have used MRI data to further personalize cancer medicine (Photo courtesy of Pexels)

Glioblastoma multiforme (GBM), a brain cancer that has an average survival rate of just one year, can be difficult to treat because of its highly dense core, rapid growth, and location. Clinicians find it difficult to quickly and accurately estimate the diffusivity and proliferation rate for these tumors in an individual patient. Now, researchers have created a computational model that uses MRI data to predict the growth of these deadly brain tumors more accurately.

Researchers at the University of Waterloo (Waterloo, ON, Canada) analyzed MRI data from several sufferers of GBM using machine learning in order to better predict the progression of cancer. The team analyzed two sets of MRIs from each of five GBM patients who underwent extensive MRIs, waited for months, and then received another set of MRIs. Since these patients opted not to receive any treatment or intervention during this time, the researchers were provided a unique opportunity to examine how GBM grows when left unchecked by analyzing their MRIs.

Using a deep learning model, the researchers turned the MRI data into patient-specific parameter estimates that inform a predictive model for GBM growth. They applied this technique to the patients’ and synthetic tumors, for which the true characteristics were known, allowing them to validate the model. The scientists now have a good model of how GBM grows untreated and will now expand the model to include the impact of treatment on the tumors. The data set would then grow from a handful of MRIs to thousands. According to the researchers, access to MRI data – and partnership between mathematicians and clinicians – can significantly impact patients in the future.

“The integration of quantitative analysis into healthcare is the future,” said Cameron Meaney, a PhD candidate in Applied Mathematics and the study’s lead researcher.

Adjustable Mobile Barrier
M-458
Biopsy Software
Affirm® Contrast
Digital Color Doppler Ultrasound System
MS22Plus
Digital Radiographic System
OMNERA 300M

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.